Trademark Overview
On Wednesday, April 29, 2026, a trademark application was filed for ZELIS NSA CLAIM ADVANTAGE with the United States Patent and Trademark Office. The USPTO has given the ZELIS NSA CLAIM ADVANTAGE trademark a serial number of 99796095. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Wednesday, April 29, 2026. This trademark is owned by ZELIS HEALTHCARE, LLC. The ZELIS NSA CLAIM ADVANTAGE trademark is filed in the Computer & Software Services & Scientific Services category with the following description:
Software as a service (SAAS) services featuring software using artificial intelligence (AI) for managing the No Surprises Act dispute lifecycle between healthcare providers and payers, including claim pricing, automated eligibility validation, predictive outcome modeling, independent dispute resolution workflows, and defending financial outcomes through claim pricing analytics; Platform as a service (PAAS) featuring computer software platforms for managing the No Surprises Act dispute lifecycle between healthcare providers and payers, including claim pricing, automated eligibility validation, predictive outcome modeling, independent dispute resolution workflows, and defending financial outcomes through claim pricing analytics; Platform as a service (PAAS) featuring computer software platforms for optimizing healthcare No Surprises Act payment dispute performance, providing real-time case visibility, and utilizing predictive intelligence to inform negotiation strategies and manage arbit...
